ALX ONCOLOGY HOLDINGS INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2021 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Alx Oncology Holdings Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2021 to Q4 2024.
  • Alx Oncology Holdings Inc Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2024 was $4.02M, a 17% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $4.02M -$824K -17% Dec 31, 2024 10-K 2025-03-06
Q3 2024 $4.23M -$810K -16.1% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $4.44M -$796K -15.2% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $4.65M -$786K -14.5% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $4.85M -$779K -13.8% Dec 31, 2023 10-K 2025-03-06
Q3 2023 $5.04M -$849K -14.4% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $5.24M -$845K -13.9% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $5.43M +$433K +8.66% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $5.63M +$3.8M +208% Dec 31, 2022 10-K 2024-03-07
Q3 2022 $5.89M +$3.99M +210% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $6.08M +$3.98M +190% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $5M +$4.7M +1567% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $1.83M Dec 31, 2021 10-K 2023-03-09
Q3 2021 $1.9M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $2.1M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $300K Mar 31, 2021 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.